Mindset operates a platform for developing an IP portfolio of next-generation psychedelic medicines and related manufacturing processes.

Investment Highlights

Analyst Coverage



Maxim Group LLC

Michael Okunewitch

H.C. Wainwright & Co.

Patrick R. Trucchio, CFA

Echelon Capital Markets

Stefan Quenneville, CFA

Mindset Pharma Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Mindset Pharma Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Mindset Pharma Inc. or its management. Mindset Pharma Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Subscribe for latest news